Teva Pharmaceutical Finance Netherlands III BV

CUSIP: 88167AAS0 Class: Corporate Bond - Foreign US$

Pacer Advisors, Inc.'s Holding History (CIK: 0001616667)

Note: Option positions (PUT/CALL) are excluded.

Q2 2025
Shares 90,000 Value ($000) $98 Avg Close — Range —
Q1 2025
Shares 50,000 Value ($000) $54 Avg Close — Range —
Q4 2024
Shares 100,000 Value ($000) $108 Avg Close — Range —
Q2 2024
Shares 74,000 Value ($000) $80 Avg Close — Range —
Q1 2024
Shares 140,000 Value ($000) $150 Avg Close — Range —
Q4 2023
Shares 140,000 Value ($000) $151 Avg Close — Range —
Q3 2023
Shares 140,000 Value ($000) $142 Avg Close — Range —
Q2 2023
Shares 140,000 Value ($000) $145 Avg Close — Range —